CXCL8 and metabolic dysfunction-associated steatohepatitis: In this regard, the use of transgenic mice engineered to express the human IL8 gene, including its regulatory elements, presents a promising avenue for understanding the impact of IL8 under conditions conducive to NASH development [46].